Angelini Farmaceutica to distribute Benferol® in Spain

Consilient Health is pleased to announce that we have signed a long term, exclusive agreement with Angelini Farmaceutica S.A for them to launch and distribute Benferol® in the Spanish market.

“Spain is an extremely important territory for Benferol® “, commented Executive Vice Chairman Luke Crosbie.  “We are delighted to be partnering with a company as well-respected and successful as Angelini and look forward to a successful launch in Spain later this year”.

Spain is a new territory for the Consilient Health portfolio and it further strengthens our geographic reach within Europe and the Middle East.

 

 

Code No: UK/CH/0519/0074

Date of Preparation: May 2019